Across 2,085 disclosed consumer transactions analyzed for this report, the same demand signals appear repeatedly — in the categories absorbing capital, the breakout rounds, and the $1bn+ acquisitions on the pages that follow. Six of those signals stand out.
About half of US consumers and two-thirds of Gen Z report ongoing functional-nutrition purchases. Appearance has replaced weight management as the third-ranked wellness priority for under-25 buyers, and McKinsey sizes the category at $2 trillion. Notable transactions: Poppi ($1.95bn to PepsiCo, prior period), Grüns ($1.2bn to Unilever), and Bioniq (up to $150m to Herbalife).
ChatGPT now has 800 to 900 million weekly active users, and roughly one in three global consumers shop through social commerce, up from one in four in 2023. The late-stage DTC market is repricing around this shift in product discovery. Notable transactions: Quince ($500m Series E), Whatnot ($225m Series F), and Nothing ($200m Series C).
Goldman Sachs cut its 2026 US disposable cash flow growth forecast from 5.1% to 3.7%, with the bottom income quintile expanding at less than 1%. Four in five global consumers are trading down on at least one category, with capital following both ends of the spread. Notable transactions: Slate Auto ($1.35bn across two affordable-EV rounds), Gopuff ($250m from Eldridge), and Creed ($4.7bn to strategic) on the premium side.
Bain counted 113 high-growth US consumer brands each holding less than 2% market share, but together capturing roughly 36% of FMCG growth in 2025. Institutional capital builds these brands; strategic acquirers buy them once consumer behavior validates the model. Notable transactions: Rhode ($1bn to e.l.f.), Grüns ($1.2bn to Unilever), and Poppi ($1.95bn to PepsiCo), all of which started as insurgents.
US consumers report roughly three additional hours of weekly free time relative to 2019, with close to 90% spent on solo activity. Fitness, hobbies, and racket sports lead the activity mix, and capital has followed. Notable transactions: Pickleball Inc. ($225m minority from Apollo), Topgolf ($1.1bn carve-out to Leonard Green), and BOLT Ventures' seven sports IP positions across padel, motorsport, and junior golf.
Three themes are reshaping beauty deal flow: GLP-1-driven body composition, sleep optimization, and advanced suncare. Insurgent challengers captured nearly all of 2025's sector growth, and the global beauty market is projected at $794.5bn by 2029. Notable transactions: Rhode ($1bn to e.l.f.), Olaplex ($1.4bn from Advent to Henkel), Creed ($4.7bn to strategic), and ELEMIS (queued sale from L'Occitane).
The six trends are not independent. The wellness economy and the GLP-1 / beauty reset overlap on prestige skincare. AI-driven discovery and insurgent-brand dominance reinforce each other. Income tiering and solo-activity trends both create demand for affordability and authenticity in tandem. The institutional capital flowing into consumer brands is responding to demand patterns the consultancies are already measuring; the question for investment firms is which patterns will produce the next reference exits.
Sources: Bain, McKinsey, Forerunner, Goldman Sachs, BeautyMatter, and a16z reporting from May 2025 through May 2026.
Forty-nine brand acquisitions priced at $1bn or above closed in the trailing twelve months, across food, beverage, beauty, apparel, footwear, hair care, supplements, retail, sports, hospitality, and travel. Four exceeded $15bn: Kellanova, JETRO/Restaurant Depot, OPAP, and JDE Peet's. The activity spans every quarter and every consumer category.
Of the 49 billion-dollar brand acquisitions in the trailing year, the mega-deals sit in food (Kellanova at $35.9bn to Mars, JDE Peet's at $18.4bn to Keurig Dr Pepper) and apparel/footwear (Skechers at $9.4bn to 3G, PUMA at $1.8bn). The nine selected below cover both ends of the buyer spectrum: strategic acquirers (Mars, Henkel, Keurig Dr Pepper, e.l.f., Clorox) and PE platforms (3G on Skechers, Advent exiting Olaplex into Henkel).
Consumer capital is not spreading evenly across the sector. Six categories produced the deepest disclosed transaction activity in the trailing year, together accounting for $60bn+ in deal value across roughly 400 transactions. Three are wellness-anchored (functional beverages, clean beauty, better-for-you food); three map to other documented demand shifts (sports IP, premium pet, late-stage DTC).
The six categories share two properties that explain why capital is concentrating in them. Each is anchored by a documented consumer behavior shift visible in Dakota's transaction data, and each has produced at least one $1bn+ exit or breakout round in the trailing year that strategics now use as a pricing reference. The combination matters: a documented demand shift gives investors a growth story; a recent reference exit gives them an underwriting case. Categories with one but not the other — plant-based meat, where demand softened, or smart home, where exits are absent — do not show up in the dataset at scale.
A seventh adjacent category, celebrity-led consumer brands, has matured past novelty into a deal category with its own playbook and exit track record. The cohort is profiled in detail in a later section.
Two cohorts of investors back consumer dealmaking. Eight pure-play consumer specialists in North America and Europe wrote three or more checks in the trailing year. The generalist platforms (Lightspeed, Accel, Bessemer, Bain Capital Ventures, Sequoia, Tiger Global, plus the PE giants) wrote more aggregate volume but spread checks across all sectors. For a brand raising capital, a consumer-specialist lead is a narrow set of options; generalist-platform capital means competing against every other sector for the same dollars.
India is the most active early-stage consumer market in the dataset: 274 of 2,085 disclosed transactions (13% of global), $4.2bn disclosed value, Mumbai the single most active consumer-deal metro worldwide at 158 deals. The Indian specialist universe writes deeper than the NA and European cohort, with more than a dozen firms at five or more checks. Fireside Ventures led with 25 deals; Blume, 360 ONE Capital, Sauce.VC, Anicut, IPV, Titan Capital, Spring Marketing, Rainmatter, and RPSG Capital each wrote six to ten.
Family office activity matches the GP volume. Premji Invest wrote four checks (GIVA, Emversity, iD Fresh), Sekhsaria three across organic food (Khetika, Two Brothers, FruBon), and Verlinvest four around Blue Tokai and adjacents. The pre-IPO pipeline (Zepto $450m, Meesho $271m, Wakefit, Milky Mist with Temasek) is the queued public-exit wave. For firms without Indian-consumer exposure, it is worth noting that Mumbai alone logged more consumer deals in the trailing year than any other city in the dataset.
Allocators have two real choices for consumer exposure: back the narrow specialist cohort, or take generalist-platform exposure where consumer is one slice of a multi-sector portfolio. The specialist cohort is concentrated enough that a single LP relationship with two firms (L Catterton and Lerer Hippeau at five checks each) captures the majority of pure-play consumer activity in NA and Europe. The generalist platforms (Lightspeed, Accel, Bessemer) wrote 8-17 consumer checks each but spread the dollars across all sectors; consumer exposure through them is incidental rather than dedicated. The strategic acquirers (Mars, Henkel, e.l.f., Clorox, Unilever, PepsiCo, Keurig Dr Pepper) buy at the back end of the cycle. The question for allocators is who held the asset when the strategic showed up, and whether the position came from a specialist with a thesis or a generalist with a portfolio slot.
886 venture and growth equity rounds closed in the trailing twelve months. The median Seed round was $3m and the median Series B $20m. The seven rounds in the table below cleared 5x to 15.5x those medians. Each company maps directly to a trend or category profiled earlier in the report.
Slate Auto's $650m Series C at 15.5x (TWG Global lead, Apr 2026) is the highest-multiple growth round in the trailing year, taking Slate Auto's disclosed TTM funding to $1.35bn. Generalist firms (Tiger, Coatue, Insight, Apollo, Bessemer, Lightspeed) lead the largest checks at Series B and beyond; pure-play consumer specialists (CAVU on Crazy Mountain) anchor the Seed-stage breakouts. Each row maps to a category the report has already profiled: affordable EV, premium pet, sleep, clean beauty, sports IP, functional beverages, and late-stage DTC.
Two private capital pools sit alongside the institutional GPs in consumer dealmaking: family offices and celebrity-led brands. Family office activity is mapped by category in Exhibit 4. The celebrity-led institutional cohort follows.
Celebrity-led brands have crossed an institutional threshold. Rhode's $1bn sale to e.l.f. set a new benchmark for the category, and the seven brands in the table below each cleared $63m with named institutional buyers in the trailing twelve months. The cohort now spans clean beauty (Rhode), RTD spirits (Long Drink), apparel (Skims), sports IP (Pickleball Inc., Kings League), creator media (MrBeast), and personalized nutrition (Bioniq) — a category mix that did not exist as institutional deal flow five years ago. Imaginary Ventures is the most active dedicated institutional backer; on the buyer side, e.l.f., Mark Anthony, Herbalife, Apollo, BOLT, and BDT & MSD have all priced against the band. The shift matters for investors: celebrity-led is no longer a novelty bucket but a deal category with reference multiples, named buyers, and a queued pipeline (BERO with Tom Holland, Reale Actives, and additional Imaginary-backed launches).
The trailing twelve months produced 2,085 disclosed consumer transactions, $250bn in deal value, and 49 billion-dollar brand exits. Five implications for the next twelve to eighteen months follow. The firms positioned for these waves have a proven thesis across consecutive quarters; the rest are bidding without a position to defend.
Looking further ahead, three second-order effects bear watching. First, the gradual easing of financing conditions should unlock primary buyout activity at the large-cap end of consumer, potentially releasing deal backlog that has been sitting in sponsor pipelines since 2023. Second, sustained strategic M&A momentum from the Mars and Kellanova-type acquirers will pull public-company consumer boards into active portfolio reviews, producing a secondary wave of carve-out supply. Third, sponsor dry powder remains historically elevated, and the combination of deployment pressure and category selectivity means premium consumer assets in the right categories (clean beauty, functional beverages, sports IP) will continue to attract robust competition, while average-quality assets may languish.
Dakota tracks every consumer transaction in detail, including the deal type, target, buyers, sellers, sector, industry, geography, and announced date. When a brand is acquired, a celebrity-led launch closes, a family office writes a check, or a sponsor exits, Dakota captures it and puts it in front of you.
Dakota is a financial, software, data and media company based in Philadelphia, PA. Dakota's flagship product, Dakota Marketplace, is a database of LPs, GPs, Private Companies and Public Companies used by thousands of fundraising, deal, and investment teams worldwide to raise capital, source deals, track peers, and access comprehensive data, all in one global platform.
For more information, book a demo of Dakota Marketplace.